Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Iwona Flisiak, Przemysław Zaniewski & Bożena Chodynicka. (2008) Plasma TGF-β1, TIMP-1, MMP-1 and IL-18 as a combined biomarker of psoriasis activity. Biomarkers 13:5, pages 549-556.
Read now
Read now
I. Flisiak, A. Klepacki & B. Chodynicka. (2006) Plasma and scales levels of interleukin 18 in comparison with other possible clinical and laboratory biomarkers of psoriasis activity. Biomarkers 11:2, pages 194-200.
Read now
Read now
Articles from other publishers (24)
Tamilselvi Elango, Anburaj Jeyaraj, Haripriya Dayalan, Pushpa Gnanaraj, Xinghui Li & Xuejun Zhang. 2022. Psoriasis - New Research. Psoriasis - New Research.
Somayyeh Khalilzadeh, Laila Shirbeigi, Ayeh Naghizadeh, Mozhgan Mehriardestani, Safar Shamohammadi & Malihe Tabarrai. (2019) Use of mineral waters in the treatment of psoriasis: Perspectives of Persian and conventional medicine. Dermatologic Therapy, pages e12969.
Crossref
Crossref
Felipe Cabezas, Pamela Farfán & María-Paz Marzolo. (2019) Participation of the SMAD2/3 signalling pathway in the down regulation of megalin/LRP2 by transforming growth factor beta (TGF-ß1). PLOS ONE 14:5, pages e0213127.
Crossref
Crossref
Galal El-Anany, Samar El-Tahlawi & Heba Abdel-Quader. (2018) Personalized medicine in dermatological practice. Journal of the Egyptian Womenʼs Dermatologic Society 15:2, pages 59-61.
Crossref
Crossref
Agnieszka Owczarczyk-Saczonek, Joanna Czerwińska & Waldemar Placek. (2018) The role of regulatory T cells and anti-inflammatory cytokines in psoriasis. Acta Dermatovenerologica Alpina Pannonica et Adriatica 27:1.
Crossref
Crossref
Mircea Tampa, Maria-Isabela Sarbu, Madalina-Irina Mitran, Cristina-Iulia Mitran, Clara Matei & Simona-Roxana Georgescu. (2018) The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis, a Stress-Related Skin Disease. Disease Markers 2018, pages 1-14.
Crossref
Crossref
S.E. Dunphy, C.M. Sweeney, G. Kelly, A.M. Tobin, B. Kirby & C.M. Gardiner. (2017) Natural killer cells from psoriasis vulgaris patients have reduced levels of cytotoxicity associated degranulation and cytokine production. Clinical Immunology 177, pages 43-49.
Crossref
Crossref
Aristeidis H. Katsanos, Kalliroi Kyriakidi, Fotini B. Karassa, Dimitrios Politis, Alexandros Skamnelos, Dimitrios K. Christodoulou & Konstantinos H. Katsanos. 2017. Biomarkers for Endometriosis. Biomarkers for Endometriosis
41
75
.
Lilla Landeck, Christoph Kneip, Joachim Reischl & Khusru Asadullah. (2016) Biomarkers and personalized medicine: current status and further perspectives with special focus on dermatology. Experimental Dermatology 25:5, pages 333-339.
Crossref
Crossref
Tamilselvi Elango, Anand Thirupathi, Swapna Subramanian, Haripriya Dayalan & Pushpa Gnanaraj. (2015) Methotrexate normalized keratinocyte activation cycle by overturning abnormal keratins as well as deregulated inflammatory mediators in psoriatic patients. Clinica Chimica Acta 451, pages 329-337.
Crossref
Crossref
Yun Zhang, Xiao-Ming Meng, Xiao-Ru Huang, Xiao-Jing Wang, Liu Yang & Hui Yao Lan. (2014)
Transforming growth factor-
β
1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice
. Clinical and Experimental Pharmacology and Physiology 41:11, pages 921-932.
Crossref
Crossref
Abdel-Raheim M. A. Meki & Hani Al-Shobaili. (2014) Serum Vascular Endothelial Growth Factor, Transforming Growth Factor β1, and Nitric Oxide Levels in Patients With Psoriasis Vulgaris: Their Correlation to Disease Severity. Journal of Clinical Laboratory Analysis 28:6, pages 496-501.
Crossref
Crossref
Ai-ping Feng, Yi-min He, Xin-xin Liu, Jia-wen Li, Ya-ting Tu, Feng Hu & Shan-juan Chen. (2014) Expression of USP15, TβR-I and Smad7 in psoriasis. Journal of Huazhong University of Science and Technology [Medical Sciences] 34:3, pages 415-419.
Crossref
Crossref
A.G.M. Hendriks, R.R.M.C. Keijsers, E.M.G.J. de Jong, M.M.B. Seyger & P.C.M. van de Kerkhof. (2013)
Combinations of
classical
time-honoured topicals in plaque psoriasis: a systematic review
. Journal of the European Academy of Dermatology and Venereology 27:4, pages 399-410.
Crossref
Crossref
Javed Mohammed, Andrew J. Gunderson, Hong-Hanh Khong, Richard D. Koubek, Mark C. Udey & Adam B. Glick. (2013) TGFβ1 Overexpression by Keratinocytes Alters Skin Dendritic Cell Homeostasis and Enhances Contact Hypersensitivity. Journal of Investigative Dermatology 133:1, pages 135-143.
Crossref
Crossref
I. Flisiak, P. Zaniewski, M. Rogalska-Taranta & B. Chodynicka. (2012) Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations. Journal of the European Academy of Dermatology and Venereology 26:3, pages 302-307.
Crossref
Crossref
Adam B. Glick. (2012)
The Role of TGF
Signaling in Squamous Cell Cancer: Lessons from Mouse Models
. Journal of Skin Cancer 2012, pages 1-12.
Crossref
Crossref
Kai Michaelis, Katrin Wallbrecht, Andreas Kerstan, Niklas Beyersdorf, Cortny Williams, Thomas Kerkau, Xiao‐Jing Wang, Thomas Hünig & Michael P. Schön. (2010) Modulating T cell functions does not alleviate chronic inflammatory skin lesions in K5.TGFβ1 transgenic mice. Experimental Dermatology 19:5, pages 406-415.
Crossref
Crossref
Gangwen Han, Cortny A. Williams, Kelli Salter, Pamela J. Garl, Allen G. Li & Xiao-Jing Wang. (2010) A Role for TGFβ Signaling in the Pathogenesis of Psoriasis. Journal of Investigative Dermatology 130:2, pages 371-377.
Crossref
Crossref
P. G. Kallimanis, K. Xenos, S. L. Markantonis, P. Stavropoulos, G. Margaroni, A. Katsambas & G. Avgerinou. (2009) Serum levels of transforming growth factor-β1 in patients with mild psoriasis vulgaris and effect of treatment with biological drugs. Clinical and Experimental Dermatology 34:5, pages 582-586.
Crossref
Crossref
Moon Chul JungMin Kyung ShinKyung Kook HongKi Heon JeongNack In Kim. (2008) Differential Expression of TGF-β Isoforms in Human Kerationocytes by Narrow Band UVB. Annals of Dermatology 20:3, pages 113.
Crossref
Crossref
J. Joachim, N. François, P. Piccerelle, J. Kister, J.-P. Reynier, P. Humbert & F. Aubin. (2005) Mécanismes et traitements du psoriasis. La Presse Médicale 34:22, pages 1727-1736.
Crossref
Crossref
Iwona Flisiak, Piotr Porebski & Bozena Chodynicka. (2005) Effect of Psoriasis Activity on Metalloproteinase‐1 and Tissue Inhibitor of Metalloproteinase‐1 in Plasma and Lesional Scales. Acta Dermato-Venereologica -1:1, pages 1-1.
Crossref
Crossref
I Flisiak, H Mysliwiec & B Chodynicka. (2005) Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1. Journal of the European Academy of Dermatology and Venereology 19:4, pages 418-421.
Crossref
Crossref